首頁 > 市場調查報告書 > 醫療設備

透析設備

連續性腎臟替代療法（CRRT）市場規模、佔有率和成長分析（按治療方法、最終用戶、年齡層和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1897216

連續性腎臟替代療法（CRRT）市場規模、佔有率和成長分析（按治療方法、最終用戶、年齡層和地區分類）—2026-2033年產業預測

Continuous Renal Replacement Therapy Market Size, Share, and Growth Analysis, By Modality, By End User, By Age Group, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，連續性腎臟替代療法 (CRRT) 市場規模將達到 15.1 億美元，到 2025 年將達到 16.3 億美元，到 2033 年將達到 30.4 億美元，在預測期（2026-2033 年）內，複合年成長率為 8.1%。

腎臟疾病和急性腎損傷盛行率的上升預計將顯著推動對連續性腎臟替代療法（CRRT）的需求。人口老化以及老年人腎功能障礙風險的增加，預計將推動CRRT解決方案市場的發展。此外，嚴重腎臟疾病患者數量的增加以及CRRT技術的進步也創造了新的成長機會。新興市場醫療費用支出的成長以及人們對創新腎臟療法日益成長的興趣，有望提升CRRT服務提供者的收入前景。然而，高昂的治療費用、潛在的併發症、熟練專業人員的短缺以及嚴格的監管要求等挑戰，可能會在未來阻礙CRRT的廣泛應用。

全球連續性腎臟替代療法 (CRRT) 市場按產品、治療方法、年齡層、最終用戶和地區進行細分。依產品分類，CRRT 市場分為透析液和替代液、一次性耗材以及 CRRT 系統。依治療方法分類，CRRT 市場分為連續性靜脈-靜脈血液濾過 (CVVHF)、連續性靜脈-靜脈血液透析濾過 (CVHDF)、連續性靜脈-靜脈血液透析 (CVHD) 和慢速超過濾(SCUF)。依年齡層別分類，CRRT 市場分為成人、兒童和新生兒。按最終用戶分類，CRRT 市場分為醫院、門診診所、居家醫療和其他最終用戶。按地區分類，CRRT 市場分為北美、歐洲、亞太地區、中東和非洲以及拉丁美洲。

連續性腎臟替代療法市場促進因素

全球連續性腎臟替代療法 (CRRT) 市場的主要促進因素之一是慢性腎臟病(CKD) 和急性腎損傷 (AKI) 在全球人群中的盛行率不斷上升。糖尿病、高血壓和心血管疾病等文明病的增加，顯著提高了對有效腎臟替代療法的需求。此外，人口老化推動了對先進醫療技術的需求，進一步促進了 CRRT 的應用。同時，CRRT 設備的技術進步正在改善患者預後並提高醫療機構的營運效率，進一步推動市場成長，使這些治療方法成為重症監護管理的重要組成部分。

限制連續性腎臟替代療法市場的因素

全球連續性腎臟替代療法（CRRT）市場的主要限制因素之一是CRRT設備的購買和維護成本高。預算限制使得許多醫療機構，尤其是發展中地區的醫療機構，難以對先進的透析技術進行投資。儘管CRRT在治療急性腎損傷方面具有許多益處，但此經濟障礙可能會阻礙其廣泛應用。此外，CRRT操作流程複雜，需要醫護人員接受專門培訓，這可能導致醫療機構難以分配有效實施和運作所需的資源，從而進一步加劇了市場挑戰。

連續性腎臟替代療法（CRRT）市場趨勢

在連續性腎臟替代療法（CRRT）市場，人工智慧（AI）的融合應用已成為提升治療效果和改善患者預後的顯著趨勢。醫療機構正加速採用AI驅動的解決方案，以實現即時患者監測、併發症預測分析以及基於個別患者需求的個人化治療。此舉旨在簡化治療流程，並提升CRRT患者照護水準。隨著醫療保健產業日益擁抱技術創新，AI的整合應用有望徹底革新臨床實踐，並推動CRRT領域的成長和創新。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Baxter International, Inc.（US）
Fresenius Medical Care AG & Co. KGaA（Germany）
Nikkiso Co., Ltd.（Japan）
B. Braun Melsungen AG（Germany）
Medtronic PLC（Ireland）
Asahi Kasei Corporation（Japan）
Toray Medical Co., Ltd.（Japan）
Nipro Corporation（Japan）
Infomed SA（Switzerland）
Medica SPA（Italy）
Medites Pharma Spol. SRO（Czech Republic）
Medical Components, Inc.（US）
SWS Hemodialysis Care Co., Ltd.（China）
Ningbo Tianyi Medical Devices Co., Ltd.（China）
Anjue Medical Equipment Co., Ltd.（China）
Kimal（UK）
Jiangxi Sanxin Medtech Co., Ltd.（China）
Allmed Medical Products Co., Ltd.（China）
Dialco Medical Inc.（US）
Browndove Healthcare Pvt. Ltd.（India）
Steris PLC（US）
Kuraray Medical PLC（Japan）
Livanova PLC（UK）
Diaverum Deutschland GmbH（Germany）
Sembcorp Industries（Singapore）

簡介目錄

Product Code: SQMIG35A2403

Continuous Renal Replacement Therapy Market size was valued at USD 1.51 Billion in 2024 and is poised to grow from USD 1.63 Billion in 2025 to USD 3.04 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The rising prevalence of kidney disorders and acute kidney injuries is set to significantly drive the demand for continuous renal replacement therapy (CRRT). An aging population, coupled with an increased risk of kidney dysfunction among older adults, is anticipated to boost the market for CRRT solutions. Additionally, the growing number of patients with severe kidney conditions and technological advancements in CRRT present new opportunities for expansion. Increased healthcare spending in emerging markets and a rising interest in innovative kidney treatments are likely to enhance revenue prospects for CRRT providers. However, challenges such as high treatment costs, potential complications, a shortage of skilled professionals, and strict regulatory requirements may hinder broader adoption of CRRT in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Renal Replacement Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Renal Replacement Therapy Market Segments Analysis

Global Continuous Renal Replacement Therapy Market is segmented on the product, modality, age group, end user, and region. By product, market is segmented into dialysate & replacement fluids, disposables, and CRRT Systems. By modality, market is segmented into continuous venovenous hemofiltration, continuous venovenous hemodiafiltration, continuous venovenous hemodialysis, and slow continuous ultrafiltration. By age group, market is segmented into adults, and pediatrics & neonates. By end user, market is segmented into hospitals, ambulatory care, home care, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Continuous Renal Replacement Therapy Market

One of the key market drivers for the Global Continuous Renal Replacement Therapy (CRRT) market is the increasing prevalence of chronic kidney diseases (CKD) and acute kidney injury (AKI) among the global population. As lifestyle diseases, diabetes, hypertension, and cardiovascular conditions escalate, the need for effective renal replacement therapies grows significantly. Additionally, the rising aging population demands advanced medical technologies, further propelling the adoption of CRRT. Moreover, technological advancements in CRRT devices that enhance patient outcomes and improve operational efficiencies in healthcare settings are also driving market growth, making these therapies essential components in critical care management.

Restraints in the Continuous Renal Replacement Therapy Market

One significant market restraint for the global Continuous Renal Replacement Therapy (CRRT) market is the high cost associated with the procurement and maintenance of CRRT equipment. Many healthcare facilities, especially in developing regions, face budget constraints that limit their ability to invest in advanced dialysis technologies. This financial barrier can hinder the widespread adoption of CRRT, despite its benefits in managing acute kidney injury. Additionally, the complexity of CRRT procedures requires specialized training for healthcare providers, which further contributes to the market's challenges as facilities may struggle to allocate the necessary resources for effective implementation and operation.

Market Trends of the Continuous Renal Replacement Therapy Market

The Continuous Renal Replacement Therapy (CRRT) market is witnessing a notable trend towards the integration of artificial intelligence (AI) to enhance treatment efficacy and patient outcomes. Providers are increasingly adopting AI-driven solutions that enable real-time monitoring of patients, predictive analytics for potential complications, and the personalization of therapy based on individual patient needs. This shift not only aims to optimize the efficiency of treatment procedures but also seeks to improve overall patient care standards within CRRT. As healthcare increasingly embraces technological advancements, the incorporation of AI is set to revolutionize practices, driving growth and innovation within the CRRT sector.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Patent Analysis
Trade Analysis
Technology Analysis
Value Chain Analysis
Customer & Buying Criteria Analysis

Continuous Renal Replacement Therapy Market, By Product

Market Overview
Dialysate & Replacement Fluids
Disposables
- Hemofilters
- Bloodline Sets & Tubes
- Other Disposables
CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality

Market Overview
Continuous Venovenous Hemofiltration
Continuous Venovenous Hemodiafiltration
Continuous Venovenous Hemodialysis
Slow Continuous Ultrafiltration

Continuous Renal Replacement Therapy Market, By Age Group

Market Overview
Adults
Pediatrics & Neonates

Continuous Renal Replacement Therapy Market, By End User

Market Overview
Hospitals
Ambulatory Care
Home Care
Other End Users

Continuous Renal Replacement Therapy Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Baxter International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikkiso Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toray Medical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Infomed SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medica SPA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medites Pharma Spol. S.R.O. (Czech Republic)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medical Components, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SWS Hemodialysis Care Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ningbo Tianyi Medical Devices Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anjue Medical Equipment Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kimal (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangxi Sanxin Medtech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allmed Medical Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dialco Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Browndove Healthcare Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Steris PLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuraray Medical PLC (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Livanova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diaverum Deutschland GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sembcorp Industries (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments